Intensivist coverage and critically ill COVID-19 patient outcomes: a population-based cohort study

Table 3 Subgroup analysis for in-hospital mortality

Variable	OR (95% CI)	P-value
WHO clinical progression scale: 1 point
Intensivist group (vs non-intensivist group)	0.80 (0.55, 1.28)	0.375
WHO clinical progression scale: 2 points
Intensivist group (vs non-intensivist group)	0.75 (0.60, 0.89)	< 0.001
WHO clinical progression scale: 3 points
Intensivist group (vs non-intensivist group)	0.73 (0.60, 0.87)	< 0.001
WHO clinical progression scale: 4 points
Intensivist group (vs non-intensivist group)	0.67 (0.45, 0.82)	< 0.001
WHO clinical progression scale: 5 points
Intensivist group (vs non-intensivist group)	0.92 (0.80, 1.18)	0.218
WHO clinical progression scale: 6 points
Intensivist group (vs non-intensivist group)	0.68 (0.47, 0.99)	0.048
ARDS group
Intensivist group (vs non-intensivist group)	0.64 (0.41, 0.98)	0.042
Hospital level group A
Intensivist group (vs non-intensivist group)	0.89 (0.59, 1.34)	0.577
Hospital level group B
Intensivist group (vs non-intensivist group)	0.60 (0.28, 1.25)	0.170
Hospital level group C
Intensivist group (vs non-intensivist group)	0.72 (0.59, 0.88)	0.001
Hospital level group D
Intensivist group (vs non-intensivist group)	0.55 (0.23, 1.35)	0.191

OR odds ratio, CI confidence interval, HFNC high flow nasal cannula, ECMO extracorporeal membrane oxygenation, CRRT continuous renal replacement therapy, ARDS acute respiratory distress syndrome

ISSN: 2052-0492